Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-05-10
2011-05-10
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S04400A, C514S785000, C514S788000, C514S943000, C554S053000, C560S168000, C564S159000
Reexamination Certificate
active
07939505
ABSTRACT:
This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents such as nucleic acid therapeutics to cells, tissues, organs, and subjects.
REFERENCES:
patent: 4844884 (1989-07-01), Tur
patent: 5141751 (1992-08-01), Tomikawa et al.
patent: 5310542 (1994-05-01), Au et al.
patent: 5357026 (1994-10-01), Younes
patent: 5376640 (1994-12-01), Miyazaki et al.
patent: 5504228 (1996-04-01), Morelle et al.
patent: 5658885 (1997-08-01), Lee et al.
patent: 5820873 (1998-10-01), Choi et al.
patent: 5831005 (1998-11-01), Zuckerman et al.
patent: 5849276 (1998-12-01), Guskey et al.
patent: 5908777 (1999-06-01), Lee et al.
patent: 5935936 (1999-08-01), Fasbender et al.
patent: 5965188 (1999-10-01), Bland et al.
patent: 5977301 (1999-11-01), Zuckerman et al.
patent: 5980935 (1999-11-01), Kirpotin et al.
patent: 6030946 (2000-02-01), Klaus et al.
patent: 6287591 (2001-09-01), Semple et al.
patent: 6335468 (2002-01-01), Hatajima et al.
patent: 6379965 (2002-04-01), Boutin
patent: 6458381 (2002-10-01), Sourovoi et al.
patent: 6656499 (2003-12-01), Foldvari et al.
patent: 6749863 (2004-06-01), Chang et al.
patent: 6815432 (2004-11-01), Wheeler et al.
patent: 6858225 (2005-02-01), Semple et al.
patent: 6897196 (2005-05-01), Szoka et al.
patent: 7312206 (2007-12-01), Panzner et al.
patent: 7335509 (2008-02-01), Huang et al.
patent: 7341738 (2008-03-01), Semple et al.
patent: 7371404 (2008-05-01), Panzner et al.
patent: 2003/0130237 (2003-07-01), Miller et al.
patent: 2004/0131666 (2004-07-01), Panzner et al.
patent: 2004/0204377 (2004-10-01), Rana
patent: 2005/0064595 (2005-03-01), MacLachlan et al.
patent: 2005/0186586 (2005-08-01), Zamore et al.
patent: 2005/0222396 (2005-10-01), Bao et al.
patent: 2005/0239687 (2005-10-01), Divita
patent: 2005/0265955 (2005-12-01), Raman et al.
patent: 2005/0287627 (2005-12-01), Hashimoto et al.
patent: 2006/0009507 (2006-01-01), Miller et al.
patent: 2006/0211637 (2006-09-01), Scaria et al.
patent: 2007/0129305 (2007-06-01), Divita
patent: 2007/0260055 (2007-11-01), Rana
patent: 2008/0020058 (2008-01-01), Chen et al.
patent: 2008/0286866 (2008-11-01), Quay et al.
patent: 2064480 (1971-07-01), None
patent: 4311806 (1994-06-01), None
patent: 0136879 (1985-04-01), None
patent: 0320976 (1989-06-01), None
patent: 0490379 (1991-12-01), None
patent: 0763592 (1997-03-01), None
patent: 0805147 (1997-05-01), None
patent: 1060739 (2000-12-01), None
patent: 1264591 (2002-12-01), None
patent: 1325735 (2003-07-01), None
patent: PCT/US2008/078627 (2009-10-01), None
patent: PCT/US2009/060930 (2010-08-01), None
patent: WO02053583 (2002-07-01), None
patent: 2355013 (2001-11-01), None
patent: 63-189288 (1988-08-01), None
patent: 02088549 (1990-03-01), None
patent: 04026662 (1992-01-01), None
patent: 2000128725 (2000-05-01), None
patent: 2000128725 (2000-09-01), None
patent: 9101724 (1991-02-01), None
patent: 9403468 (1994-02-01), None
patent: 9640737 (1996-12-01), None
patent: 9705865 (1997-02-01), None
patent: WO9725070 (1997-07-01), None
patent: 9743363 (1997-11-01), None
patent: 9915506 (1999-04-01), None
patent: 9933787 (1999-08-01), None
patent: 9952936 (1999-10-01), None
patent: 0015206 (2000-03-01), None
patent: 0073471 (2000-12-01), None
patent: 0171022 (2001-09-01), None
patent: 0198362 (2001-12-01), None
patent: 02072068 (2002-09-01), None
patent: 02002538 (2002-10-01), None
patent: 02078448 (2002-10-01), None
patent: 03024402 (2003-03-01), None
patent: 03091276 (2003-11-01), None
patent: 03091276 (2003-11-01), None
patent: 03106636 (2003-12-01), None
patent: 2005032494 (2005-04-01), None
patent: 2005039629 (2005-05-01), None
patent: 2005068488 (2005-07-01), None
patent: 2005105152 (2005-10-01), None
patent: 2005102997 (2005-11-01), None
patent: 2006001381 (2006-05-01), None
patent: 2006082978 (2006-10-01), None
patent: 2007001455 (2007-01-01), None
patent: 2007027742 (2007-03-01), None
patent: 2007039736 (2007-04-01), None
patent: 2008042973 (2008-04-01), None
patent: WO2009046220 (2009-04-01), None
Epand, R. et al., “Properties of lipoamino acids incorporated into membrane bilayers,” Biochimica et Biophysica Acta, v. 1373, No. 1, pp. 67-75, Elsevier, 1998.
Heyes, J. et al., “Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids,” Journal of Controlled Release, v. 107, No. 2, pp. 276-287, Elsevier, 2005.
MacDonald, M. et al., “Physical and Biological Properties of Cationic Triesters of Phosphatidylcholine,” Biophysical Journal, v. 77, pp. 2612-2629, 1999.
Reshetnyak, Y. et al., “Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix,” PNAS, v. 103, No. 17, pp. 6460-6465, 2006.
Rossi, J., “SNALPing siRNAs in vivo,” Gene Therapy, v. 13, pp. 583-584, Nature Publishing Group, 2005.
Saleh, M. et al., “The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing,” Nature Cell Biology, v. 8, No. 8, pp. 793-802, 2006.
Hafez, I. et al. “Tunable pH-Sinsitive Liposomes Composed of Mixtures of Cationic and Anionic Lipids,” Biophysical Journal, v. 79, No. 3, pp. 1438-1446, 2000.
Wang, K. et al. “Synthesis and in vitro Behavior of Multivalent Cationic Lipopeptide for DNA Delivery and Release in HeLa Cells,” Bioconjugate Chemistry, v. 18, No. 6, pp. 1735-1738, American Chemical Society, 2007.
Gonzalez, H. et al., “New Class of Polymers for the Delivery of Macromolecular Therapeutics,” Bioconjugate Chemistry, v. 10, pp. 1068-1074, 1999.
Thomas, M., et al., “Non-viral siRNA delivery to the lung” Advanced Drug Delivery Reviews 59 (2007) pp. 124-133.
Thomas, M., et al., “Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung” PNAS , v. 102 No. 16, 2005.
Prata, C., et al., “Lipophilic Peptides for Gene Delivery” Bioconjugate Chem., vol. 19, No. 2, 2008.
Rudraksh, S., et al., “Molecular modeling of arginine-glycine-aspartic acid (RGD) analogs Relevance to Transepithelial transport” J Pharm Pharmaceut Sci (www.ualberta.ca/˜csps) 4(1):32-41, 2001.
Opal, S., et al., “Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis” Journal of Endotoxin Research, v. 7, No. 1, pp. 35-39, 2001.
Ma, B., et al. “Lipoplex morphologies and their influences on transfection efficiency in gene delivery” Journal of Controlled Release, 123, pp. 184-194, 2007.
Yaghmur, A., et al., “Tuning Curvature and Stability of Monoolein Bilayers by Designer Lipid-Like Peptide Surfactants” PLoS ONE 2(5): e479. doi:10.1371/journal.pone.0000479, (2007).
David, S., et al. “Lipopolyamines: Novel Antiendotoxin Compounds That Reduce Mortality in Experimental Sepsis Caused by Gram-Negative Bacteria” Antimicrobial Agents and Chemotherapy, v.43 No. 4, pp. 912-919, 1999.
Bedford, M., et al. “Arginine Methylation: An Emerging Regulator of Protein Function” Molecular Cell, v. 18, pp. 263-272, 2005.
Vavrova K, et al., “Synthetic ceramide analogues as skin permeation enhancers: structure-activity relationships” Bioorganic & Medicinal Chemistry, Elsevier Science LTD, v. 11, No. 24, pp. 5381-5390, 2003.
Fan, G., et al., “Synthesis of alpha-galactosyl ceramide and the related glycolipids for evaluation of their activities on mouse splenocytes” Tetrahedron, Elsevier Science Publishers, v. 61, No. 7, pp. 1855-1862, 2005.
Polidori, A.., et al., “Vesicles and other supramolecular systems made from double-tailed synthetic glycolipids derived from galactosylated tris (hydroxymethyl) aminomethane” Chemistry and Physics of Lipids, v. 77, No. 2, pp. 225-251, 1995.
Tonges, L., et al., “Stearylated octaarginine and artificial virus-like particles for transfection of siRNA
Adami Roger C.
Fam Renata
Fosnaugh Kathy Lynn
Harvie Pierrot
Houston, Jr. Michael
Eckman Basu LLP
Marina Biotech, Inc.
Russel Jeffrey E
LandOfFree
Amino acid lipids and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid lipids and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid lipids and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2664065